Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TRANSITION THERAPEUTICS INC. T.TTH

Healthcare Biotechnology
"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."

Recent & Breaking News (TSX:TTH)

OPKO Health Completes Acquisition of Transition Therapeutics

Business Wire August 31, 2016

Benzinga's M&A Chatter for Friday August 26, 2016

Benzinga.com  August 28, 2016

Transition Therapeutics Shareholders Approve Acquisition by OPKO Health

Business Wire August 26, 2016

Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.

Canada NewsWire August 25, 2016

OPKO Health to Acquire Transition Therapeutics

Business Wire June 30, 2016

Transition Therapeutics Receives Notification From NASDAQ

Canada NewsWire June 3, 2016

Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results

Canada NewsWire May 11, 2016

Asterias Biotherapeutics Announces Proposed Public Offering

PR Newswire May 9, 2016

Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST

Canada NewsWire May 9, 2016

Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701

Canada NewsWire April 25, 2016

Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401

Canada NewsWire April 18, 2016

Transition Therapeutics Receives Notification From NASDAQ

Canada NewsWire March 17, 2016

Transition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference

PR Newswire March 1, 2016

Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results

Canada NewsWire February 9, 2016

Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST

Canada NewsWire February 5, 2016

Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401

Canada NewsWire February 1, 2016

Transition Therapeutics Announces Annual General Meeting Voting Results

Canada NewsWire January 6, 2016

Transition Therapeutics to Host Investor Day November 23 in New York

Canada NewsWire November 19, 2015

Transition Therapeutics Announces First Quarter Fiscal 2016 Financial Results

Canada NewsWire November 10, 2015

Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST

Canada NewsWire November 2, 2015